Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bradford S. Hoppe, MD, MPH"'
Autor:
Alexander J. Tun, Bradford S. Hoppe, MD, MPH, Yujie Zhao, MD, PhD, Ian Makey, MD, Sebastian Fernandez-Bussy, MD, Xiaoying Liang, PhD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 302-305 (2023)
Primary adenoid cystic carcinoma of the trachea (ACC-T) is an extremely rare cancer of the central bronchial system. It is usually associated with an excellent prognosis. Surgery is the standard treatment for resectable tumors, while radiation therap
Externí odkaz:
https://doaj.org/article/2d699a4bf4124f9aa1121e2496338b9f
Autor:
Michael S. Rutenberg, MD, PhD, Bradford S. Hoppe, MD, MPH, Jason S. Starr, DO, Ziad Awad, MD, Mathew Thomas, MBBS, MD, Christopher G. Morris, MS, Perry Johnson, PhD, Randal H. Henderson, MD, MBA, Jeremy C. Jones, MD, Bharatsinh Gharia, MBBS, MD, Steven Bowers, MD, Herbert C. Wolfsen, MD, Sunil Krishnan, MBBS, MD, Stephen J. Ko, MD, Hani M. Babiker, MD, Romaine C. Nichols, Jr, MD
Publikováno v:
International Journal of Particle Therapy, Pp 18-29 (2022)
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the hear
Externí odkaz:
https://doaj.org/article/6e0ce34c85cc410c8a3e146ab69d68ad
Autor:
Jonathan A. Baron, MD, Christopher M. Wright, MD, Russell Maxwell, MD, Michele M. Kim, PhD, Fantine Giap, MD, Raymond B. Mailhot Vega, MD, MPH, Bradford S. Hoppe, MD, MPH, Michael J. LaRiviere, MD, Amit Maity, MD, PhD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101090- (2023)
Purpose: Combined modality therapy with multiagent chemotherapy and radiation therapy is a standard treatment option for aggressive mediastinal non-Hodgkin lymphomas (AMNHLs); however, concerns regarding acute and late radiation toxicities have fuele
Externí odkaz:
https://doaj.org/article/684c562a7fd7413887bbb92aacfaa521
Autor:
James E. Bates, MD, Stephanie Terezakis, MD, Christopher G. Morris, MS, Avani D. Rao, MD, Shuchi Sehgal, BA, Rahul Kumar, MBBS, Raymond B. Mailhot Vega, MD, MPH, Nancy P. Mendenhall, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 21-27 (2021)
Purpose: Early stage (stages I-II) classical Hodgkin lymphoma (cHL) is a highly curable disease typically diagnosed in adolescents and young adults (AYAs). Proton therapy can also reduce the late toxicity burden in this population, but data on its co
Externí odkaz:
https://doaj.org/article/4662bd6f283b47d2addc8493de90f859
Autor:
Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 1-16 (2021)
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding
Externí odkaz:
https://doaj.org/article/871926a9f47046e99a4987b232eaa487
Autor:
Shivam M. Kharod, MD, Catherine E. Mercado, MD, Christopher G. Morris, MS, Curtis M. Bryant, MD, MPH, Nancy P. Mendenhall, MD, William M. Mendenhall, MD, R. Charles Nichols, MD, Bradford S. Hoppe, MD, MPH, Xiaoying Liang, PhD, Zhong Su, PhD, Zuofeng Li, DSc, Randal H. Henderson, MD, MBA
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 4, Pp 52-64 (2021)
Purpose: Postprostatectomy radiation improves disease control, but limited data exist regarding outcomes, toxicities, and patient-reported quality of life with proton therapy. Method and Materials: The first 102 patients who were enrolled on an outco
Externí odkaz:
https://doaj.org/article/8f335a2fb6b5444383014baf7ca5424e
Autor:
Raymond B. Mailhot Vega, MD, MPH, Sharon M. Castellino, MD, MSc, Qinglin Pei, PhD, Susan Parsons, MD, MRP, Kenneth B. Roberts, MD, David Hodgson, MD, MPH, Anne-Marie Charpentier, MD, Thomas J. Fitzgerald, MD, Sandy K. Kessel, Frank G. Keller, Kara Kelly, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 55-57 (2021)
Externí odkaz:
https://doaj.org/article/26833359dfdd4977a89be74a7e0e7ed4
Autor:
Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 1-10 (2020)
Purpose: Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment o
Externí odkaz:
https://doaj.org/article/be204a5aa19b43449b4e30ecf3ffe4a1
Autor:
Omran Saifi, MD, Mohamed A. Kharfan-Dabaja, MD, MBA, Youssef H. Zeidan, MD, PhD, Jennifer Peterson, MD, William G. Rule, MD, Scott C. Lester, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 1, Pp 13-20 (2020)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Since the relapse rate of DLBCL to frontline chemoimmunotherapy and salvage autologous hematopoietic cell transplant is high, CD19-directed chimeric antigen recept
Externí odkaz:
https://doaj.org/article/d2b2a05efa3744b7a500528e8c08ed24
Autor:
Adam L. Holtzman, MD, John M. Stahl, MD, Simeng Zhu, MD, Christopher G. Morris, MS, Bradford S. Hoppe, MD, MPH, Jessica E. Kirwan, MA, Nancy P. Mendenhall, MD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 699-705 (2019)
Background: Conventional radiation therapy (RT) has produced unprecedented cure rates in patients with Hodgkin's lymphoma (HL) but exposed large volumes of nontargeted tissue to radiation (integral dose). Objective: Our goal was to report the effects
Externí odkaz:
https://doaj.org/article/c7be407ca5fe4cf58232cd2632fe7cbf